Search Results - Gabriel Man

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Application of systems biology to identify pharmacological mechanisms of thrombotic microangiopathy evoked by combined activated prothrombin complex concentrate and emicizumab by Raquel Valls, Jonathan Wagg, Ido Paz-Priel, Gabriel Man, Laura Artigas, Georges Jaccard, Mireia Coma, Christophe Schmitt

    Published in Scientific Reports (2023-06-01)
    Get full text
    Article


  2. 2

    Integrated summary of immunogenicity of polatuzumab vedotin in patients with relapsed or refractory B-cell non-Hodgkin’s lymphoma by Randall C. Dere, Richard L. Beardsley, Dan Lu, Tong Lu, Grace H-W. Ku, Gabriel Man, Van Nguyen, Surinder Kaur

    Published in Frontiers in Immunology (2023-03-01)
    Get full text
    Article


  3. 3

    Population pharmacokinetics and exposure–response analyses of polatuzumab vedotin in patients with previously untreated DLBCL from the POLARIX study by Rong Deng, Leonid Gibiansky, Tong Lu, Christopher R. Flowers, Laurie H. Sehn, Qi Liu, Priya Agarwal, Michael Z. Liao, Randall Dere, Calvin Lee, Gabriel Man, Jamie Hirata, Chunze Li, Dale Miles

    Get full text
    Article


  4. 4

    Analysis of peripheral neuropathy in the POLARIX study using clinician- and patient-reported outcomes by Marek Trněný, Laura Fogliatto, Faithlore Gardner, Ian Flinn, Jean-François Larouche, Corinne Haioun, Miguel Canales, Hideki Goto, Roman Hajek, Gilles Salles, Avrita Singh, Mark Yan, Rucha Kothari, Gabriel Man, Deniz Sahin, Jamie Hirata, Calvin Lee, Hervé Tilly, Christopher R. Flowers

    Published in Blood Advances (2025-07-01)
    Get full text
    Article


Search Tools: